TransMedics Group Inc (TMDX)

Receivables turnover

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Revenue (ttm) US$ in thousands 441,540 401,090 358,759 296,919 241,623 191,824 151,077 119,133 93,459 71,752 51,439 39,089 30,262 28,221 29,942 25,162 25,639 24,069 24,183 26,458
Receivables US$ in thousands
Receivables turnover

December 31, 2024 calculation

Receivables turnover = Revenue (ttm) ÷ Receivables
= $441,540K ÷ $—K
= —

The data provided for TransMedics Group Inc's receivables turnover ratio shows that the ratio was not available for each reporting period from March 31, 2020, to December 31, 2024. The absence of specific data on receivables turnover limits our ability to assess the company's efficiency in collecting outstanding receivables from customers during these periods.

Receivables turnover ratio is a key financial metric that indicates how many times a company collects its average accounts receivable balance during a specific period. A higher turnover ratio generally signifies that the company is efficient in managing its accounts receivable and converting sales into cash promptly. Conversely, a low turnover ratio may indicate potential issues with collecting receivables, which can impact cash flow and overall liquidity.

Given the lack of data on receivables turnover, it is challenging to gauge the effectiveness of TransMedics Group Inc's credit and collection policies, as well as its overall working capital management strategy. It would be beneficial for stakeholders and investors to have access to this information in order to gain deeper insights into the company's financial operations and performance in relation to its receivables management.


Peer comparison

Dec 31, 2024